β-cell genes and diabetes: Quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1α and glucokinase mutations

Diabetes

Volumn 50, Issue SUPPL. 1, 2001, Pages

  Pearson, Ewan R ^a   Velho, Gilberto ^c   Clark, Penny ^b   Stride, Amanda ^a   Shepherd, Maggie ^a   Frayling, Timothy M ^a   Bulman, Michael P ^a   Ellard, Sian ^a   Froguel, Phillipe ^d   Hattersley, Andrew T ^a,e  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c HÔPITAL SAINT VINCENT DE PAUL   (France)

^d Institut Pasteur de Lille   (France)

^e School of Postgraduate Medicine and Health Sciences   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; GLUCOSE; INSULIN; NUCLEAR FACTOR I; TRANSCRIPTION FACTOR;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; GENE MUTATION; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HETEROZYGOTE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MATURITY ONSET DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0035122350     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.2007.s101     Document Type: Conference Paper

References (45)

1. Maturity-onset diabetes of the young: Clinical heterogeneity explained by genetic heterogeneity
2. Familial hyperglycemia due to mutations in glucokinase: Definition of a subtype of diabetes mellitus
3. Mutations in the hepatocyte nuclear factor-1α gene are a common cause of maturity-onset diabetes of the young in the U.K.
4. β-cell genes and diabetes: Molecular and clinical characterization of mutations and transcription factors
5. Glucokinase gene structure: Functional implications of molecular genetic studies
6. Glucokinase as glucose sensor and metabolic signal generator in pancreatic β-cell and hepatocytes
7. Glucokinase as pancreatic beta cell glucose sensor and diabetes gene
8. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus
9. Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families
10. Clinical characteristics of subjects with a missense mutation in glucokinase
11. Linkage of type 2 diabetes to the glucokinase gene
12. Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young
13. Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations
14. Impaired hepatic glycogen-synthesis in glucokinase-deficient (MODY2) subjects
15. Insulin resistance as the major cause of impaired glucose tolerance: A serf-fulfilling prophesy?
16. Mutations in the hepatic nuclear factor 1 alpha gene in maturity-onset diabetes of the young (MODY3)
17. A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q
18. Mutations in the hepatocyte nuclear factor 1α gene in MODY and early-onset NIDDM: Evidence for a mutational hotspot in exon 4
19. Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity onset diabetes of the young (MODY3)
20. Novel MODY3 mutations in the hepatic nuclear factor-1α gene: Evidence for a hyperexcitability of pancreatic β-cells to intravenous secretagogues in a glucose-tolerant career of a P447L mutation
21. Disruption of the HNF-4α promoter in an Italian family with MODY
22. Novel mutations and a mutational hotspot in the MODY3 gene
23. Mutations in the hepatocyte nuclear factor-1α/MODY3 gene in Japanese subjects with early- and late-onset NIDDM
24. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12
25. Characterization of the MODY3 phenotype: Early-onset diabetes caused by an insulin secretion defect
26. Insulin secretion and insulin sensitivity in diabetic and non-diabetic subjects with hepatic nuclear factor-1 alpha (maturity-onset diabetes of the young-3) mutations
27. Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice
28. The relation of proinsulin and insulin to insulin sensitivity and acute insulin response in subjects with newly diagnosed type II diabetes: The Insulin Resistance Atherosclerosis Study
29. Evolution of beta-cell dysfunction in impaired glucose tolerance and diabetes
30. Elevated plasma proinsulin/insulin ratio is a marker of reduced insulin secretory capacity in healthy young men
31. Glucokinase deficiency results in a beta-cell disorder characterised by normal fasting plasma proinsulin concentrations
32. Specific insulin and proinsulin secretion in glucokinase deficient individuals
33. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria
34. Sensitive and specific two site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins
35. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
36. Correct homeostasis model assessment (HOMA) evaluation uses the computer program
37. Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes
38. Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes
39. Hyperexcitability to sulphonylurea in MODY3
40. Sensitivity to sulphonylureas in patients with hepatocyte nuclear factor 1 alpha gene mutations: Evidence for pharmacogenetics in diabetes
41. Assessment of insulin sensitivity in glucokinase-deficient subjects
42. Defective pancreatic β-cell glycolytic signalling in hepatocyte nuclear factor-1α-deficient mice
43. Beta-cell secretory defect caused by mutations in glucokinase gene
44. Mutations in the glucokinase gene of the fetus result in reduced birth weight
45. Maturity onset diabetes of the young: A missed diagnosis